Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY conjugate versus ACWY polysaccharide priming and booster B-cell response study in adults
2007-001349-17Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of Meningococcal ACWY conjugate vaccine and quadrivalent meningococcal polysaccharide vaccine in meningococcal disease, meningitis and bloodstream infection (BSI) (2 arms), sponsored by University of Oxford. Primary endpoints: Serogroup A SBA GMT comparison and Serogroup C, W-135 and Y SBA GMT comparison. Started Apr 2009; status: completed.
02
Drugs
Meningococcal ACWY conjugate vaccinequadrivalent meningococcal polysaccharide vaccine
03
Conditions
meningococcal diseasemeningitisbloodstream infection (BSI)
Beyond the preview
Go deeper on 2007-001349-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001349-17.